Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses
Authors
Keywords
Hemorrhage, Cost-effectiveness analysis, Ischemic stroke, Hong Kong, Hemorrhagic stroke, Atrial fibrillation, Anticoagulants, Thromboembolism
Journal
PLoS One
Volume 11, Issue 6, Pages e0157129
Publisher
Public Library of Science (PLoS)
Online
2016-07-01
DOI
10.1371/journal.pone.0157129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
- (2014) Shinya Goto et al. AMERICAN HEART JOURNAL
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
- (2014) Craig T. January et al. CIRCULATION
- Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
- (2014) Masahiro Yasaka et al. CIRCULATION JOURNAL
- Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
- (2014) Gregory Y.H. Lip et al. CLINICAL THERAPEUTICS
- Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
- (2014) P. Dorian et al. EUROPEAN HEART JOURNAL
- Oral anticoagulants for Asian patients with atrial fibrillation
- (2014) Ian Sabir et al. Nature Reviews Cardiology
- Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
- (2014) Jelena Stevanović et al. PLoS One
- Stroke prevention in atrial fibrillation: An Asian perspective
- (2014) Kang-Ling Wang et al. THROMBOSIS AND HAEMOSTASIS
- Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation
- (2014) Tereza Lanitis et al. THROMBOSIS RESEARCH
- Stroke prevention in atrial fibrillation—An Asian stroke perspective
- (2013) Hung-Fat Tse et al. HEART RHYTHM
- Significant Underuse of Warfarin in Patients with Nonvalvular Atrial Fibrillation: Results from the China National Stroke Registry
- (2013) Chunjuan Wang et al. Journal of Stroke & Cerebrovascular Diseases
- Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
- (2013) Valery L Feigin et al. LANCET
- Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin
- (2013) Ida Ehlers Albertsen et al. STROKE
- Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
- (2013) Raffaele Caterina et al. THROMBOSIS AND HAEMOSTASIS
- Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia
- (2013) Zanfina Ademi et al. European Journal of Preventive Cardiology
- Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding
- (2012) Daniel M. Witt et al. ARCHIVES OF INTERNAL MEDICINE
- Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong
- (2012) Jason C. S. Ho et al. CLINICAL CARDIOLOGY
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
- (2012) Soyon Lee et al. PLoS One
- Catalogue of EQ-5D Scores for the United Kingdom
- (2011) Patrick W. Sullivan et al. MEDICAL DECISION MAKING
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis
- (2010) Charlotte JJ van Asch et al. LANCET NEUROLOGY
- Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed
- (2009) Stephen J. Boccuzzi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
- (2008) Daniel O. Claassen et al. ARCHIVES OF NEUROLOGY
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
- (2008) Stuart J. Connolly et al. CIRCULATION
- Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation
- (2008) Yi Wan et al.
- Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control
- (2008) Christopher Ll. Morgan et al. THROMBOSIS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now